FROUNT is an activation cofactor of CCR2 and CCR5 involved in macrophage chemotaxis, and a FROUNT inhibitor enhances the anticancer effect of immunotherapy via suppressing TAM infiltration in cancer tissue [112]. The gene discussed is NUP85; the disease is cancer.